Milgamma Mono 150 (Benfotiamine)

Benfotiamine, the active ingredient in Milgamma Mono 150, is a thiamine derivative presented as an oral supplement for oral use. It supports carbohydrate metabolism and nerve function, and is used primarily as a vitamin B1 supplement in adults with metabolic or neuropathic concerns.

GNH USA supplies Milgamma Mono 150 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Benfotiamine is a vitamin B1 derivative that acts on metabolic pathways and peripheral nerve health. It is employed in the following clinical situations: - Diabetic peripheral neuropathy: helps alleviate nerve pain and sensory deficits associated with long‑term diabetes. - Alcohol‑induced neuropathy: supports nerve regeneration and reduces tingling sensations caused by chronic alcohol use. - General thiamine deficiency: restores normal carbohydrate metabolism when dietary intake of vitamin B1 is insufficient.

Benfotiamine is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Headache: transient mild headache. - Diarrhea: loose stools in sensitive individuals. - Skin rash: mild erythema or itching. - Dizziness: occasional light‑headed feeling.

Serious or Rare Side Effects: - Hypersensitivity reaction: swelling, hives, or difficulty breathing. - Severe skin eruption: Stevens‑Johnson‑like rash. - Hepatic enzyme elevation: abnormal liver function tests. - Anaphylaxis: rapid onset of severe allergic response.

Before using Benfotiamine, consider the following safety measures. - Renal function assessment: adjust use if severe kidney impairment is present. - Blood glucose monitoring: observe for unexpected changes in diabetic patients. - Pregnancy and lactation: use only if clearly needed, as safety data are limited. - Known hypersensitivity: avoid if allergic to benfotiamine or related thiamine compounds. - Dosage adherence: do not exceed the prescriber's recommendation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Benfotiamine may interact with certain medicines; awareness helps prevent issues.

Major Interactions (Avoid): - None identified: no major drug‑drug interactions have been reported for benfotiamine.

Moderate Interactions (Monitor Closely): - Alcohol: concurrent use may diminish the supplement’s nerve‑protective effect. - Diuretics: may increase urinary thiamine loss, potentially reducing efficacy. - Anticonvulsants (e.g., phenobarbital): can accelerate thiamine metabolism, requiring closer monitoring. - Chemotherapeutic agents: theoretical risk of altered vitamin metabolism; monitor nutritional status.